Bausch Health Companies Inc (NYSE:BHC)
| 8.51 Delayed Data As of Jun 29 |  -0.32 / -3.62%Today’s Change | 6.88 Today|||52-Week Range 30.30 | -69.18% Year-to-Date |
Latest BHC News | Press Releases
| Why Bausch Health Stock Is Bolting Higher Today Jun 24 / MotleyFool.com - Paid Partner Content | Bausch (BHC) Suspends IPO Plans for Solta Medical Jun 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 8.83 |
| Today’s open | 8.80 |
| Day’s range | 8.37 - 8.80 |
| Volume | 4,628,004 |
| Average volume (3 months) | 6,201,563 |
| Market cap | $3.2B |
Data as of 4:00pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | -67.44% |
| Earnings growth (this year) | -11.04% |
| Earnings growth (next 5 years) | +8.79% |
| Revenue growth (last year) | +5.07% |
| P/E ratio | NM |
| Price/Sales | 1.17 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRFSGrifols SA | -1.00 | -8.13% |
| ---- | ||
| FOLDAmicus Therapeutics ... | +0.20 | +1.84% |
| PBHPrestige Consumer He... | -0.06 | -0.11% |
Data as of 4:00pm ET, 06/29/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | $0.92 |
| Annual revenue (last year) | $8.4B |
| Annual profit (last year) | -$948.0M |
| Net profit margin | -11.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
